Author:
El-Hadaad Hend Ahmed,Wahba Hanan Ahmed
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Reference24 articles.
1. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Stat Fact Sheets. 2009. http://seer.cancer.gov/csr/1975_2009_pops09, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
2. Ferlay J, Autier P, Boniol M, Heanue M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–92.
3. Burris 3rd HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–13.
4. Androulakis N, Syrigosk, Polyzos A, Hellenic Oncology Research Group, et al. Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study. Cancer Invest. 2005;93:9–12.
5. Hochster H, Chachoua A, Speyer J, et al. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer. J Clin Oncol. 2003;21(14):2703–7.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献